Noticias de la Fundación del SPF

Doctores Reclutando Pacientes con SPF para Estudios de Investigación

SOMERSET, N.J., June 16, 2014 – Post-finasteride syndrome research initiatives at two major U.S. medical institutions, Brigham and Women’s Hospital (a Harvard Medical School Teaching Affiliate) in Boston, Mass., and Baylor College of Medicine in Houston, Texas, are currently recruiting patients for their respective studies on the condition. If you are interested in participating, or […]

Discurso Anual de la Fundación SPF 2013

Aug. 4, 2013 Dear Friends: When we incorporated the Post-Finasteride Syndrome Foundation in July 2012, our mission was clear: To fund research on the characterization, underlying biologic mechanisms and treatments of PFS while raising public awareness of this often life-altering condition afflicting thousands of men the world over. Now, on the occasion of our one-year […]

Estudio Clínico del Síndrome Post-Finasterida Lanzado en la Facultad de Medicina de Baylor

SOMERSET, N.J., Aug. 21, 2013 – The Post-Finasteride Syndrome Foundation today announced the funding of a second major clinical study on post-finasteride syndrome (PFS), this one at Baylor College of Medicine (BCM) in Houston, Texas. Titled “Genetic and Epigenetic Studies on Post-Finasteride Syndrome Patients,” the research is being led by Mohit Khera (right), MD, MBA, […]

Dudas al Paciente con SPF: Casos de Suicidio

  August 7, 2013   Dear Friends: The PFS Foundation is seeking information about patients who have taken finasteride or dutasteride, and who have attempted suicide or who have completed suicide. This is an area of active research interest and researchers are seeking to obtain medical records and other relevant material for such patients. To […]

Estudio Clínico del Síndrome Post-Finasterida Lanzado en Brigham and Women’s Hospital

SOMERSET, N.J., July 1, 2013 – The Post-Finasteride Syndrome Foundation today announced the funding of a major clinical study on post-finasteride syndrome (PFS) at Brigham and Women’s Hospital (BWH), a teaching affiliate of Harvard Medical School. Titled “A Preliminary, Hypothesis-Generating Investigation of the Post-Finasteride Syndrome: Description of the Phenotype, and Elucidation of the Hormonal, Genetic […]

Síntesis de Febrero de 2013 del Debate de Investigación en Mesa Redonda del SPF en Italia

SOMERSET, N.J., March 25, 2013 – The roundtable discussion at the 7th international steroids and nervous system meeting in Orbassano (TO), Italy, February 16th – 20th 2013, included scientific presentations and discussions amongst multiple medical researchers regarding the Post-Finasteride Syndrome. This event was a great opportunity for the PFS Foundation to increase awareness of PFS […]

La Fundación del Síndrome Post-Finasterida está Concedida por la IRS de Estado no Lucrativo como Entidad Pública de Beneficencia

SOMERSET, N.J., March 18, 2013 – The Post-Finasteride Syndrome Foundation today announced that it has been granted 501(c)(3) status by the Internal Revenue Service. “Nonprofit status will allow us to put more dollars to work pursuing our core goal, which is funding research on the characterization, underlying biologic mechanisms and treatments of PFS,” added Dr. […]

La Fundación del Síndrome Post-Finasterida Patrocina la Mesa Redonda del SPF con Investigadores Médicos en una Reunión acerca de los Esteroides y el Sistema Nervioso

SOMERSET, N.J., Nov. 5, 2012 – The Post-Finasteride Syndrome Foundation is sponsoring a round-table discussion on PFS at the University of Milan’s 7th International Meeting on Steroids and the Nervous System conference in Torino, Italy, Feb. 19, 2013. Titled «Effects of Finasteride Treatment on the Nervous System,» the event is being organized by Roberto Melcangi, […]

La Fundación Lanza su Página Web para Financiar la Investigación en el Síndrome Post-Finasterida

SOMERSET, N.J., Aug. 28, 2012 – The Post-Finasteride Syndrome Foundation today launched its website, PFSFoundation.org. The Foundation is dedicated to helping fund research on the characterization, underlying biologic mechanisms and treatments of post-finasteride syndrome (PFS). A secondary goal is to help increase public awareness of PFS. PFS is characterized by sexual, neurological, hormonal and psychological […]